| Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
| Tel: |
400-9205774 |
| Email: |
sales@glpbio.cn |
| Products Intro: |
Product Name:tetranor-PGFM
CAS:23109-94-6
Purity:>98% Package:1mg;10mg;50mg;100mg;
|
| Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
| Tel: |
18818260767 |
| Email: |
sales@chemegen.com |
| Products Intro: |
Product Name:tetranor-PGFM
CAS:23109-94-6
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:tetranor-PGFM
CAS:23109-94-6
Purity:98% Package:25μg;50μg;100μg
|
|
| | 9ALPHA,11ALPHA-DIHYDROXY-15-OXO-2,3,4,5-TETRANOR-PROSTAN-1,20-DIOIC ACID Basic information |
| Product Name: | 9ALPHA,11ALPHA-DIHYDROXY-15-OXO-2,3,4,5-TETRANOR-PROSTAN-1,20-DIOIC ACID | | Synonyms: | 9ALPHA,11ALPHA-DIHYDROXY-15-OXO-2,3,4,5-TETRANOR-PROSTAN-1,20-DIOIC ACID;TETRANOR-PGFM;TETRANOR PROSTAGLANDIN F METABOLITE;tetranor-PGFM Lipid Maps MS Standard;IGRHJCFWWOQYQE-SYQHCUMBSA-N;Cyclopentaneoctanoic acid, 2-(2-carboxyethyl)-3,5-dihydroxy-ε-oxo-, (1R,2R,3S,5R)- | | CAS: | 23109-94-6 | | MF: | C16H26O7 | | MW: | 330.37 | | EINECS: | | | Product Categories: | | | Mol File: | 23109-94-6.mol |  |
| | 9ALPHA,11ALPHA-DIHYDROXY-15-OXO-2,3,4,5-TETRANOR-PROSTAN-1,20-DIOIC ACID Chemical Properties |
| solubility | DMF: >100 mg/ml (from PGF2a); DMSO: >100 mg/ml (from PGF2a); Ethanol: >100 mg/ml (from PGF2a); PBS pH 7.2: >10 mg/ml (from PGF2a) |
| | 9ALPHA,11ALPHA-DIHYDROXY-15-OXO-2,3,4,5-TETRANOR-PROSTAN-1,20-DIOIC ACID Usage And Synthesis |
| Description | tetranor-PGFM is the major urinary metabolite of PGF2α. Normal healthy females excrete 7-13 μg of tetranor-PGFM per day compared to 11-59 μg/24 hours for healthy males. In pregnant females, tetranor-PGFM levels in the urine are 2 to 5-fold higher and diminish to pre-pregnancy levels soon after labor. | | Definition | ChEBI: 2,3,4,5-tetranor-prostaglandin FM is a prostanoid that is prostaglandin E2-UM in which the oxo group at position 9 has been reduced to the corresponding alcohol (alpha-configuration). It has a role as a metabolite. It is a prostanoid, an oxo dicarboxylic acid, a secondary alcohol and a ketone. |
| | 9ALPHA,11ALPHA-DIHYDROXY-15-OXO-2,3,4,5-TETRANOR-PROSTAN-1,20-DIOIC ACID Preparation Products And Raw materials |
|